Naftopidil

Description

Naftopidil is used in men to decrease the urine outflow difficulties due to an enlarged prostate gland. It is not recommended in patients with a known history of allergy to naftopidil.

Side effects

Major & minor side effects for Naftopidil

  • Dizziness
  • Headache
  • Irregular heart beat
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Itching of skin
  • Skin Rash
  • Blurred vision

Uses of Naftopidil

What is it prescribed for?

  • Benign prostatic hyperplasia
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not used in women for the indication of Benign Prostatic Hyperplasia (BPH). Use of this medicine is generally not recommended in pregnant women unless absolutely necessary if it is used for any other indications other than BPH. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not used in women for the indication of Benign Prostatic Hyperplasia (BPH). Use of this medicine is generally not recommended in breastfeeding women unless absolutely necessary if it is used for any other indications other than BPH. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to naftopidil or any other inactive ingredients present along with it.
Warnings for special population

Pregnancy

This medicine is not used in women for the indication of Benign Prostatic Hyperplasia (BPH). Use of this medicine is generally not recommended in pregnant women unless absolutely necessary if it is used for any other indications other than BPH. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not used in women for the indication of Benign Prostatic Hyperplasia (BPH). Use of this medicine is generally not recommended in breastfeeding women unless absolutely necessary if it is used for any other indications other than BPH. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Liver impairment

This medicine should be used with caution in patients with liver impairment due to the increased risk of adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Driving or operating machinery

Use of this medicine may cause blurred vision, weakness, dizziness, dizziness on standing up, etc. due to orthostatic hypotension in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Use in children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, the patient should be monitored closely for any adverse effects.

Syncope

This medicine should be used with caution due to the increased risk of temporary loss of consciousness caused by a sudden decrease in the blood pressure.

Other uses

Your doctor may prescribe this medicine for indications other than those stated above in certain specific circumstances, especially if other medicines are not effective. All the risks and benefits should be discussed with the doctor in such cases.

Kidney impairment

This medicine should be used with caution in patients with kidney impairment due to the increased risk of adverse effects. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Aceclofenac

Warfarin

Acemetacin

Acepromazine

Abafungin

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine after a meal or as exactly advised by the doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine before completion of the course/without consulting your doctor.
Miscelleneous

To be taken after food

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by relaxing the smooth muscles in the bladder and prostate and thus eases the urine flow.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Alpha-blockers, Adrenergic alpha-Antagonists

Schedule

Schedule H

Naftopidil - DrugBank [Internet]. Drugbank.ca. 2018 [cited 19 September 2018]. Available from:

https://www.drugbank.ca/drugs/DB12092

Naftopidil [Internet]. Pubchem.ncbi.nlm.nih.gov. 2018 [cited 19 September 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/naftopidil#

Search results detail| Kusurino-Shiori(Drug information Sheet) [Internet]. Rad-ar.or.jp. 2018 [cited 19 September 2018]. Available from:

http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=35757

[Internet]. Medind.nic.in. 2018 [cited 19 September 2018]. Available from:

http://medind.nic.in/jav/t11/i3/javt11i3p147.pdf

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 Mar 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.